Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Sep 9, 2022 (4 years ago)

Skincell Mole & Skin Corrector Serum

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Marketed Without An Approved NDA/ANDA; Unapproved new drug

Cause type: Unapproved drug

The product was marketed without an approved NDA/ANDA, or does not meet the OTC monograph it claims to follow. Nothing about the product - dose, purity, safety - has been reviewed by FDA, so the claims on the box are unverified. All unapproved drug recalls.

What was recalled

Skincell Mole & Skin Corrector Serum, 1 fl. oz./30 mL jars, Distributed By: Justified Laboratoires, Arlington, TX 76011 USA UPC 8 10077 53221 8

Recalling firm
Justified Laboratories
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0009-2023 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Justified Laboratories

All 2022 recalls

Other unapproved drug recalls from 2022

All unapproved drug recalls
Class II · Moderate risk

Launch Sequence Capsules

Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.

Terminated Unapproved drug Loud Muscle Science D-1339-2022